SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!
+1 786 238 2170

Global Stem Cells GroupGlobal Stem Cells Group

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Press Releases
  • Blog
CONTACT
  • Home
  • Press Releases
  • Global Stem Cells Group Expands Presence in Indonesia with ReGen Jakarta
July 4, 2025

Global Stem Cells Group Expands Presence in Indonesia with ReGen Jakarta

Friday, June 28, 2024 / Published in Press Releases

Global Stem Cells Group Expands Presence in Indonesia with ReGen Jakarta

Miami, Florida – Global Stem Cells Group (GSCG) is thrilled to announce the grand opening of its latest state-of-the-art Stem Cell Center, located in Jakarta, Indonesia. This new facility, under the membership of ReGen Network, marks the second center in Jakarta and the fourth in Indonesia, reflecting GSCG’s rapid and explosive growth within the regenerative medicine industry.

“Witnessing the rapid and dynamic growth of the regenerative medicine industry, particularly through the pioneering efforts of experts like Dr. Yanti, our medical director in Indonesia, is truly inspiring,” said Benito Novas, a prominent figure in regenerative medicine and the head of Public Relations for GSCG and the International Society for Stem Cell Application (ISSCA).

“The expansion of the ReGen Clinic network solidifies our position as the largest regenerative medicine network globally. Our mission is to implement the best practices in regenerative medicine across various regions, ensuring effective and transformative results,” stated Dr. Salih Yildirim, Director of ReGen and President of ISSCA.

This momentous occasion marks a significant stride forward in the field of regenerative medicine and showcases GSCG’s commitment to providing innovative healthcare solutions worldwide. In a groundbreaking partnership with an esteemed local aesthetic clinic, GSCG introduces its fourth Stem Cell Center in Indonesia, complementing existing facilities in Jakarta, Surabaya, and Bandung. Further underscoring their dedication to advancing medical research, GSCG also anticipates the unveiling of a fifth facility in Bali this year.

ReGen is at the forefront of introducing cutting-edge aesthetic and regenerative treatments, revolutionizing the healthcare landscape. Patients now can have access to the latest treatment options. This partnership underscores Global Stem Cells Group’s vision to make its exceptional services accessible to people around the world.

“We are very proud to be part of ReGen and to contribute to the advancement of regenerative medicine in Indonesia. This new center in Jakarta represents our commitment to providing top-tier medical care and innovative treatments to our patients,” said Dr. Yanti Khusmiran, Medical Director of ReGen Facilities in Indonesia.

While ReGen brings access to clinics, advanced techniques, and expertise, Global Stem Cells Group provides valuable resources as a conglomerate of companies engaged in product manufacturing and comprehensive training through ISSCA. This collaboration has the potential to change the lives of people seeking regenerative care on a global scale.

The newly established center will also serve as a training hub for ISSCA, contributing to the enhancement of knowledge and expertise among healthcare professionals in the region. The opening ceremony was accompanied by onsite training conducted by ISSCA, explaining to all staff standards of practice in regenerative medicine, medical applications of stem cells, and exosomes.

About Global Stem Cells Group

Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331

About ReGen

ReGen is a highly acclaimed Turkish company with clinics in Turkey and several other locations around the world, renowned for its expertise in cutting-edge technologies related to regenerative care. Headquartered in Istanbul, ReGen has gained international recognition for its commitment to excellence and its groundbreaking advancements in regenerative medicine. By partnering with Global Stem Cells Group, ReGen aims to share its advanced techniques and expertise on a global scale, improving access to regenerative care and transforming lives worldwide.

About Dr. Yanti Aesthetic Clinic

 Dr. Yanti Aesthetic Clinic is a revered healthcare institution renowned for its state-of-the-art aesthetic and regenerative treatments. With an unwavering dedication to excellence and a forward-thinking approach, Dr. Yanti Aesthetic Clinic is poised to shape the future of regenerative medicine in Indonesia and beyond.

Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

What you can read next

Stem Cell Training Inc. Announces Alliance with Far Eastern University to Advance in-Office Stem Cell Procedures
Stem Cell Training, Inc. Announces Joint Venture with The Research Center in Tissue Engineering and Cellular Therapy at Maimonides University
Global Stem Cells Group, Inc. Announces Plans to Attend 21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine in Las Vegas, Dec. 15, 2013

Send Us a Message

Contact Home GSCG website

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.
  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

TOP